Hypophosphatasia
📧 Sign up to get email alerts when something new happens for Hypophosphatasia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-18EMA Authorised: Strensiq (asfotase alfa) — Alexion Europe SAS
The EMA authorised Strensiq (asfotase alfa) for the treatment of hypophosphatasia. The marketing authorisation holder is Alexion Europe SAS,…
-
FDA approval · 2018-01-26FDA Approved: STRENSIQ — Supplemental Application (Alexion Pharmaceuticals, Inc.)
The FDA approved a supplemental application for STRENSIQ (asfotase alfa) from Alexion Pharmaceuticals, Inc.
-
FDA approval · 2016-10-18FDA Approved: STRENSIQ — Supplemental Application (Alexion Pharmaceuticals, Inc.)
The FDA approves a supplemental application for STRENSIQ (asfotase alfa) from Alexion Pharmaceuticals. This action updates the approved labe…
-
FDA approval · 2015-10-23FDA Approved: STRENSIQ — Original Application (Alexion Pharmaceuticals, Inc.)
The FDA approved STRENSIQ (asfotase alfa) from Alexion Pharmaceuticals in its original Biologics License Application, establishing enzyme re…